Work

645P A phase Ib dose escalation study of binimetinib plus mFOLFIRI in patients with metastatic RAS mutated colorectal cancer

Year: 2023

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.1835

Authors: V. Florou, H. Lee, C.D. Nevala-plagemann, H.P. Soares, G.W. Gilcrease, J. Whisenant, K. Barber, K. Boucher, I. Garrido-Laguna

Institutions: University of Utah, Huntsman Cancer Institute

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Amgen, Bristol-Myers Squibb, AstraZeneca, University of Utah, Exelixis, Huntsman Cancer Institute, Cedars-Sinai Medical Center, BeiGene, Incyte, Ipsen, Genentech, EMD Serono

OpenAlex ID: W4387811536

FWCI: 0.122

Cites:

Cited by: 1

Related to: 10